The pathology of AD is characterized by the accumulation of amyloid β (Aβ) and phosphorylated tau (P-tau) in the patient’s brain, with tau being a brain-specific protein that leaks from mesenchyme to plasma in AD (Mattsson et al. 2016; Scheltens et al. 2021). This evidence concerns the gene MAPT and Alzheimer disease.